Issue 42 - The Cancer Letter

Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.

SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.

LOGIN SUBSCRIBE NOW

SEARCH DATE

SEARCH TEXT

Cancel

OK

Cancel

OK

Delete Account

Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below

Steven Libutti: Trusting science as COVID's new wave looms over New Jersey

Election results notwithstanding, Trump stands poised to deliver blows to NIH, FDA, public health, research

A slice of carrot cake with cream cheese frosting will not make the turmoil go away, but it can't hurt

Living with cannabis: The goal of helping cancer patients live in comfort deserves data now

In Brief

Timothy W. Mullett named chair of the Commission on Cancer of the American College of Surgeons

Donna D. Zhang receives $7.3 million NIEHS grant to research arsenic-induced lung cancer, Type 2 diabetes

Clinical Roundup

Cancer patients, clinicians find value in electronic real-time symptom reporting

Colon cancer surgery performed by highly skilled surgeons improves long-term survival for patients

Active surveillance is safe for African Americans with low-risk prostate cancer

Nerves keep pancreatic cancer cells from starving, study finds

Large-scale cancer proteomics study profiles protein changes in response to drug treatments

Drugs & Targets

Lynparza approved in the EU as first-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer

Kymriah receives approval for commercial manufacturing in Japan

Merck to acquire VelosBio for $2.75 billion

NCI Trials

NCI Trials for Nov. 2020

Recent Issues

Renew today!

Subscriber content

Never miss an issue!

Login